Neonatal mortality risk of vulnerable newborns by fine stratum of gestational age and birthweight for 230 679 live births in nine low- and middle-income countries, 2000-2017.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hazel Elizabeth A, Erchick Daniel J, Katz Joanne, Lee Anne C C, Diaz Michael, Wu Lee S F, West Keith P, Shamim Abu Ahmed, Christian Parul, Ali Hasmot, Baqui Abdullah H, Saha Samir K, Ahmed Salahuddin, Roy Arunangshu Dutta, Silveira Mariângela F, Buffarini Romina, Shapiro Roger, Zash Rebecca, Kolsteren Patrick, Lachat Carl, Huybregts Lieven, Roberfroid Dominique, Zhu Zhonghai, Zeng Lingxia, Gebreyesus Seifu H, Tesfamariam Kokeb, Adu-Afarwuah Seth, Dewey Kathryn G, Gyaase Stephaney, Poku-Asante Kwaku, Boamah Kaali Ellen, Jack Darby, Ravilla Thulasiraj, Tielsch James, Taneja Sunita, Chowdhury Ranadip, Ashorn Per, Maleta Kenneth, Ashorn Ulla, Mangani Charles, Mullany Luke C, Khatry Subarna K, Ramokolo Vundli, Zembe-Mkabile Wanga, Fawzi Wafaie W, Wang Dongqing, Schmiegelow Christentze, Minja Daniel, Msemo Omari Abdul, Lusingu John P A, Smith Emily R, Masanja Honorati, Mongkolchati Aroonsri, Keentupthai Paniya, Kakuru Abel, Kajubi Richard, Semrau Katherine, Hamer Davidson H, Manasyan Albert, Pry Jake M, Chasekwa Bernard, Humphrey Jean, Black Robert E
Аннотация
DESIGN: Descriptive multi-country secondary data analysis.
SETTING: Nine LMICs in sub-Saharan Africa, Southern and Eastern Asia, and Latin America.
POPULATION: Liveborn infants from 15 population-based cohorts.
METHODS: Subnational, population-based studies with high-quality birth outcome data were invited to join the Vulnerable Newborn Measurement Collaboration. All studies included birthweight, gestational age measured by ultrasound or last menstrual period, infant sex and neonatal survival. We defined adequate birthweight as 2500-3999 g (reference category), macrosomia as ≥4000 g, moderate low as 1500-2499 g and very low birthweight as <1500 g. We analysed fine strata classifications of preterm, term and post-term: ≥42+0, 39+0-41+6 (reference category), 37+0-38+6, 34+0-36+6,34+0-36+6,32+0-33+6, 30+0-31+6, 28+0-29+6 and less than 28 weeks.
MAIN OUTCOME MEASURES: Median and interquartile ranges by study for neonatal mortality rates (NMR) and relative risks (RR). We also performed meta-analysis for the relative mortality risks with 95% confidence intervals (CIs) by the fine categories, stratified by regional study setting (sub-Saharan Africa and Southern Asia) and study-level NMR (≤25 versus >25 neonatal deaths per 1000 live births).
RESULTS: We found a dose-response relationship between lower gestational ages and birthweights with increasing neonatal mortality risks. The highest NMR and RR were among preterm babies born at <28 weeks (median NMR 359.2 per 1000 live births; RR 18.0, 95% CI 8.6-37.6) and very low birthweight (462.8 per 1000 live births; RR 43.4, 95% CI 29.5-63.9). We found no statistically significant neonatal mortality risk for macrosomia (RR 1.1, 95% CI 0.6-3.0) but a statistically significant risk for all preterm babies, post-term babies (RR 1.3, 95% CI 1.1-1.5) and babies born at 370-386 weeks (RR 1.2, 95% CI 1.0-1.4). There were no statistically significant differences by region or underlying neonatal mortality.
CONCLUSIONS: In addition to tracking vulnerable newborn types, monitoring finer categories of birthweight and gestational age will allow for better understanding of the predictors, interventions and health outcomes for vulnerable newborns. It is imperative that all newborns from live births and stillbirths have an accurate recorded weight and gestational age to track maternal and neonatal health and optimise prevention and care of vulnerable newborns.